Published in J Clin Invest on February 01, 1994
Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury. Kidney Int (2013) 2.08
Pathophysiology of acute kidney injury. Compr Physiol (2012) 1.56
Prostaglandin E2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat. J Clin Invest (1995) 1.06
Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury. Kidney Int (2010) 1.02
Renal endothelial dysfunction in acute kidney ischemia reperfusion injury. Cardiovasc Hematol Disord Drug Targets (2014) 0.96
Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. Am J Physiol Renal Physiol (2012) 0.96
Cellular and Molecular Mechanisms of AKI. J Am Soc Nephrol (2016) 0.83
The influence of allopurinol on kidney haemodynamic and excretory responses to renal ischaemia in anaesthetized rats. Br J Pharmacol (1999) 0.81
Expression of endothelin-1 and its receptors in Cisplatin-induced acute renal failure in mice. Korean J Physiol Pharmacol (2008) 0.80
Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts. Vasc Health Risk Manag (2009) 0.78
Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched? Heart Fail Rev (2001) 0.78
Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes. Crit Care (2015) 0.76
Renal protection in cardiovascular surgery. F1000Res (2016) 0.75
Endothelin and the renal microcirculation. Semin Nephrol (2015) 0.75
Preventive Role of Endothelin Antagonist on Kidney Ischemia: Reperfusion Injury in Male and Female Rats. Int J Prev Med (2015) 0.75
Lack of an apparent role for endothelin-1 in the prolonged reduction in renal perfusion following severe unilateral ischemia-reperfusion injury in the mouse. Physiol Rep (2016) 0.75
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest (1945) 27.11
Cloning and expression of a cDNA encoding an endothelin receptor. Nature (1991) 7.26
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (1991) 7.11
[A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics]. Klin Wochenschr (1955) 5.62
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci (1992) 4.39
The renal lesions of electrolyte imbalance. I. The structural alterations in potassium-depleted rats. J Exp Med (1957) 2.73
Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br J Pharmacol (1993) 1.51
Glomerular actions of endothelin in vivo. J Clin Invest (1989) 1.40
Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J Clin Invest (1992) 1.36
Plasma endothelin levels in patients with acute renal failure. N Engl J Med (1989) 1.36
Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am J Physiol (1993) 1.23
Regeneration after acute tubular necrosis. Kidney Int (1992) 1.20
Endothelin inhibits fluid and bicarbonate transport in part by reducing Na+/K+ ATPase activity in the rat proximal straight tubule. J Am Soc Nephrol (1991) 1.03
Pathophysiological role of endothelin in acute renal failure. Life Sci (1990) 1.03
A role for endothelin in the maintenance of post-ischaemic renal failure in the rat. J Physiol (1991) 0.99
Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol (1992) 0.96
Characterization of endothelin 1 receptor and signal transduction mechanisms in rat medullary interstitial cells. Am J Physiol (1991) 0.96
Cellular mechanisms of acute ischemic injury in the kidney. Annu Rev Med (1993) 0.92
Chronic vascular constrictions and measurements of renal function in conscious rats. Kidney Int (1979) 0.91
Intracellular electrolyte composition following renal ischemia. Kidney Int (1981) 0.87
Stimulation of DNA synthesis in kidney epithelial cells in culture by potassium. Am J Physiol (1984) 0.80
Renal actions of endothelin. Kidney Int (1993) 0.80
Rat kidney endothelin receptors in ischemia-induced acute renal failure. J Pharmacol Exp Ther (1993) 0.79
Endothelin-induced natriuresis and diuresis are pressure-dependent events in the rat. Am J Physiol (1993) 0.78
Redesigning trypsin: alteration of substrate specificity. Science (1985) 3.70
Time series analysis of air pollution and mortality: effects by cause, age and socioeconomic status. J Epidemiol Community Health (2000) 2.32
Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase is associated with phosphorylation of the beta-adrenergic receptor. Proc Natl Acad Sci U S A (1983) 1.74
Paternal exposure to pesticides and congenital malformations. Scand J Work Environ Health (1998) 1.62
SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc Natl Acad Sci U S A (1994) 1.39
Desensitization of turkey erythrocyte adenylate cyclase. Beta-adrenergic receptor phosphorylation is correlated with attenuation of adenylate cyclase activity. J Biol Chem (1984) 1.38
Effect of the thromboxane receptor antagonist, BM 13.505, on the sequelae of endotoxemia in the conscious rat. Eicosanoids (1988) 1.38
Phorbol diesters promote beta-adrenergic receptor phosphorylation and adenylate cyclase desensitization in duck erythrocytes. Biochem Biophys Res Commun (1984) 1.37
Parental agricultural work and selected congenital malformations. Am J Epidemiol (1999) 1.33
Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study. BMJ (2009) 1.25
Desensitization of the beta-adrenergic receptor of frog erythrocytes. Recovery and characterization of the down-regulated receptors in sequestered vesicles. J Biol Chem (1983) 1.24
Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis. J Thromb Haemost (2006) 1.21
Mortality study of construction workers in the UK. Int J Epidemiol (1995) 1.14
Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study. BMJ (2009) 1.12
Adrenocorticotropin-dependent particulate guanylate cyclase in rat adrenal and adrenocortical carcinoma: comparison of its properties with soluble guanylate cyclase and its relationship with ACTH-induced steroidogenesis. Arch Biochem Biophys (1982) 1.12
Respiratory diseases in children and outdoor air pollution in São Paulo, Brazil: a time series analysis. Occup Environ Med (2000) 1.11
The management of patients with ischaemic heart disease undergoing non-cardiac elective surgery: a survey of Australian and New Zealand clinical practice. Anaesthesia (2004) 1.08
Autosomal dominant zonular cataract with sutural opacities localized to chromosome 17q11-12. Am J Hum Genet (1995) 1.07
Parental education and children's respiratory and allergic symptoms in the Pollution and the Young (PATY) study. Eur Respir J (2006) 1.06
125I-labeled p-azidobenzylcarazolol, a photoaffinity label for the beta-adrenergic receptor. Characterization of the ligand and photoaffinity labeling of beta 1- and beta 2-adrenergic receptors. J Biol Chem (1982) 1.06
Involvement of G protein-coupled receptor kinase-6 in desensitization of CGRP receptors. Eur J Pharmacol (2000) 1.03
Desensitization of the turkey erythrocyte beta-adrenergic receptor in a cell-free system. Evidence that multiple protein kinases can phosphorylate and desensitize the receptor. J Biol Chem (1985) 1.03
Exposure to indoor mould and children's respiratory health in the PATY study. J Epidemiol Community Health (2008) 1.02
Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Life Sci (1986) 1.01
Nutrition and respiratory health in children in six Central and Eastern European countries. Thorax (2003) 1.01
Molecular characterization and regulation of the human endothelin receptors. J Biol Chem (1993) 1.01
Respiratory symptoms, bronchitis and asthma in children of Central and Eastern Europe. Eur Respir J (2002) 1.00
Reconstructing exposures from the UK chemical warfare agent human research programme. Ann Occup Hyg (2007) 0.97
Exposures recorded for participants in the UK Chemical Warfare Agent Human Research Programme, 1941-1989. Ann Occup Hyg (2009) 0.97
Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J Clin Endocrinol Metab (1988) 0.96
Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase. Structural alterations in the beta-adrenergic receptor revealed by photoaffinity labeling. J Biol Chem (1982) 0.95
Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int (1994) 0.94
Characterization of cholesterol ester hydrolase activities in rabbit and guinea pig aortas. Atherosclerosis (1978) 0.94
Endothelin B receptor modulates inflammatory pain and cutaneous inflammation. Mol Pharmacol (1999) 0.93
1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists. J Med Chem (1994) 0.93
Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis. J Pharmacol Exp Ther (1993) 0.92
Studies in globoid leukodystrophy: enzymatic and lipid findings in the canine form. Exp Neurol (1970) 0.92
Cell-free desensitization of catecholamine-sensitive adenylate cyclase. Agonist- and cAMP-promoted alterations in turkey erythrocyte beta-adrenergic receptors. J Biol Chem (1984) 0.92
Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol (1996) 0.92
Distribution of neutral endopeptidase activity along the rat and rabbit nephron. Pharmacology (1999) 0.92
Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line. Mol Pharmacol (1987) 0.91
Gas cooking is associated with small reductions in lung function in children. Eur Respir J (2009) 0.91
Isolation and expression of a novel angiotensin II receptor from Xenopus laevis heart. Mol Pharmacol (1993) 0.91
Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol. Am J Gastroenterol (1991) 0.90
Immune biomarkers in relation to exposure to particulate matter: a cross-sectional survey in 17 cities of Central Europe. Inhal Toxicol (2000) 0.90
Phorbol diester treatment promotes enhanced adenylate cyclase activity in frog erythrocytes. Arch Biochem Biophys (1986) 0.90
Sex difference in the antidiuretic activity of vasopressin in the rat. Am J Physiol (1993) 0.90
Effect of n-alcohols and glycerol on the pretransition of dipalmitoylphosphatidylcholine. Biochim Biophys Acta (1987) 0.90
Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line. Mol Pharmacol (1987) 0.89
Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med (1980) 0.88
Characterization of canine renal endothelin receptor subtypes and their function. J Pharmacol Exp Ther (1994) 0.87
GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats. Br J Pharmacol (2007) 0.87
Endothelin inhibits vasopressin action in rat inner medullary collecting duct via the ETB receptor. J Pharmacol Exp Ther (1993) 0.87
Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist. J Pharmacol Exp Ther (1998) 0.86
Genetic analysis of cyclic nucleotide phosphodiesterases in Drosophila melanogaster. Adv Cyclic Nucleotide Res (1981) 0.86
Molecular characterization of a novel human endothelin receptor splice variant. J Biol Chem (1996) 0.86
Regulation of lysophosphatidylcholine-metabolizing enzymes in isolated myocardial cells from rat heart. Can J Physiol Pharmacol (1985) 0.86
Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation. J Pharmacol Exp Ther (1986) 0.86
Human AT1 receptor is a single copy gene: characterization in a stable cell line. Mol Cell Biochem (1994) 0.86
Maternal occupation in the leather industry and selected congenital malformations. Occup Environ Med (1998) 0.85
Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C. Biochem J (1989) 0.85
Zidovudine-associated myopathy. Lancet (1988) 0.85
Hydrolysis of triolein, cholesterol oleate, and 4-methylumbelliferyl stearate by acid and neutral ester hydrolases (lipases) from pigeon adipose tissue: effect of cAMP-dependent protein kinase. Can J Biochem (1981) 0.84
Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2A activity in mesangial cells. Eur J Pharmacol (2000) 0.84
Identification and function of putative ETB receptor subtypes in the dog kidney. J Cardiovasc Pharmacol (1995) 0.83
Escherichia coli contamination and health aspects of soil and tomatoes (Solanum lycopersicum L.) subsurface drip irrigated with on-site treated domestic wastewater. Water Res (2012) 0.83
Tolerant Staphylococcus aureus causing vertebral osteomyelitis. Arch Intern Med (1982) 0.83
Measurement of responses from Gi-, Gs-, or Gq-coupled receptors by a multiple response element/cAMP response element-directed reporter assay. Anal Biochem (1999) 0.83
Spinal cord distribution of the somatic innervation of the external urethral sphincter of the cat. J Neurol Sci (1970) 0.83
Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line. Proc Natl Acad Sci U S A (1986) 0.83
Activation of multiple mitogen-activated protein kinases by recombinant calcitonin gene-related peptide receptor. Eur J Pharmacol (2000) 0.83
Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist. J Pharmacol Exp Ther (1996) 0.82
CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity. J Pharmacol Exp Ther (1998) 0.82
Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype? J Pharmacol Exp Ther (1998) 0.82
Cold induced rhabdomyolysis in carnitine palmyityl transferase deficiency. Can J Neurol Sci (1979) 0.82
Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide. Pharmacology (1997) 0.82
Identification of a novel kidney-specific gene downregulated in acute ischemic renal failure. Am J Physiol Renal Physiol (2000) 0.82
Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number. Eur J Pharmacol (1991) 0.82
Effect of sirolimus on the cholesterol content of aortic arch in ApoE knockout mice. Transplant Proc (2003) 0.82
Sensory perikarya in Autonomic Ganglia. Nat New Biol (1971) 0.82
Effect of lipids on insect cell growth and expression of recombinant proteins in serum-free medium. Cytotechnology (1996) 0.81
Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. J Pharmacol Exp Ther (1994) 0.81
Solubilization and reconstitution of vasopressin V1 receptors of rat liver. Mol Pharmacol (1987) 0.81
NO2 and children's respiratory symptoms in the PATY study. Occup Environ Med (2006) 0.81
Beneficial effects of the peptidoleukotriene receptor antagonist, SK&F 104353, on the responses to experimental endotoxemia in the conscious rat. Circ Shock (1988) 0.81
Induction of functional beta-adrenergic receptors in rat aortic smooth muscle cells by sodium butyrate. Biochem Pharmacol (1986) 0.81
Homologous desensitization of calcitonin gene-related peptide response in rat glomerular mesangial cells in culture. Mol Cell Biochem (1992) 0.81
Regulation of glomerular mesangial cell proliferation in culture by adrenomedullin. Eur J Pharmacol (1999) 0.81
Activation of endothelin ETB receptors increases glomerular cGMP via an L-arginine-dependent pathway. Am J Physiol (1992) 0.81
Protein kinase C regulates TNF-alpha production by human monocytes. Eur Cytokine Netw (1993) 0.80
Molecular mechanisms of homologous and heterologous desensitization mediated by vasopressin in smooth muscle cells. J Biol Chem (1989) 0.80
Demonstration of ACTH-sensitive particulate guanylate cyclase in adrenocortical carcinoma. Biochem Biophys Res Commun (1981) 0.80
Effect of streptozotocin on red-blood-cell-reduced glutathione: modification by glucose, nicotinamide, and epinephrine. Diabetes (1976) 0.80
5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity. J Med Chem (1998) 0.80
Diacylglycerol lipase and kinase activities in rat brain microvessels. Biochim Biophys Acta (1985) 0.80
Measurement of renin and substrate concentrations in human serum. Anal Biochem (1979) 0.80